Biosynex (XPAR:ALBIO) Accounts Payable & Accrued Expense : €17.4 Mil (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Biosynex Accounts Payable & Accrued Expense?

Biosynex's quarterly accounts payable & accrued expense increased from Jun. 2023 (€19.2 Mil) to Dec. 2023 (€26.4 Mil) but then declined from Dec. 2023 (€26.4 Mil) to Jun. 2024 (€17.4 Mil).

Biosynex's annual accounts payable & accrued expense declined from Dec. 2021 (€48.8 Mil) to Dec. 2022 (€19.6 Mil) but then increased from Dec. 2022 (€19.6 Mil) to Dec. 2023 (€26.4 Mil).

Biosynex Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biosynex's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosynex Accounts Payable & Accrued Expense Chart

Biosynex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5.61

37.91

48.82

19.56

26.38

Biosynex Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															9.85	19.56	19.16	26.38	17.43

Biosynex Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biosynex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biosynex SA (XPAR:ALBIO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

0DL:Germany

Address

22 Boulevard Sebastien Brant, Illkirch, FRA, 67400

Website

http://www.biosynex.com

Biosynex SA is engaged in the research, development, and manufacturing of fast diagnosis tests on membrane support for health professionals. It manufactures and markets medical devices for screening, diagnosis.

Biosynex Headlines

No Headlines